|
Security Type
|
Security Class Title
|
Fee Calculation Rule
|
Amount Registered(1)
|
Proposed Maximum Offering Price Per Unit(2)
|
Maximum Aggregate Offering Price(2)
|
Fee Rate
|
Amount of Registration Fee
|
|||||||||||||||||
|
Equity
|
Common Stock, no par value
|
Rule 457(c) and Rule 457(h)
|
2,088,988(3
|
)
|
$
|
0.93
|
$
|
1,942,758.84
|
.0000927
|
$
|
180.10 | |||||||||||||
|
Equity
|
Common Stock, no par value
|
Rule 457(c) and Rule 457(h)
|
522,247(4
|
)
|
$
|
0.93
|
$
|
485,689.71 |
.0000927
|
$
|
45.02 | |||||||||||||
|
Total Offering Amounts
|
$
|
225.12
|
||||||||||||||||||||||
|
Total Fee Offsets
|
$
|
0.00
|
||||||||||||||||||||||
|
Net Fee Due
|
$
|
225.12
|
||||||||||||||||||||||
| (1) |
Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also covers such additional shares of Common Stock as may be issued to prevent dilution
resulting from stock splits, stock dividends and similar transactions.
|
| (2) |
Pursuant to Rules 457(c) and 457(h)(1) under the Securities Act, the proposed maximum offering price per unit and the maximum aggregate offering price have been calculated solely for the purpose of computing
the registration fee on the basis of the average of the high ($0.96) and low ($0.89) prices of the Common Stock of Cyclerion Therapeutics, Inc. on the Nasdaq Global Select Market on August 5, 2022 ($0.93), such date being within five
business days of the date that this registration statement was filed with the Securities and Exchange Commission.
|
| (3) |
Represents additional shares of Common Stock authorized for issuance under the Cyclerion Therapeutics, Inc. 2019 Equity Incentive Plan.
|
| (4) |
Represents additional shares of Common Stock authorized for issuance under the Cyclerion Therapeutics, Inc. 2019 Employee Stock Purchase Plan.
|